257
Views
14
CrossRef citations to date
0
Altmetric
Articles

QSAR modelling on a series of arylsulfonamide-based hydroxamates as potent MMP-2 inhibitors

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 247-263 | Received 11 Dec 2018, Accepted 25 Feb 2019, Published online: 23 Apr 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

S. Banerjee, S.K. Baidya, N. Adhikari & T. Jha. (2022) A comparative quantitative structural assessment of benzothiazine-derived HDAC8 inhibitors by predictive ligand-based drug designing approaches. SAR and QSAR in Environmental Research 33:12, pages 987-1011.
Read now
S. Das, S.A. Amin, S. Gayen & T. Jha. (2022) Insight into the structural requirements of gelatinases (MMP-2 and MMP-9) inhibitors by multiple validated molecular modelling approaches: Part II. SAR and QSAR in Environmental Research 33:3, pages 167-192.
Read now
S. Guti, S.K. Baidya, S. Banerjee, N. Adhikari & T. Jha. (2021) A robust classification-dependent multi-molecular modelling study on some biphenyl sulphonamide based MMP-8 inhibitors. SAR and QSAR in Environmental Research 32:10, pages 835-861.
Read now
S. Banerjee, S.A. Amin, S.K. Baidya, N. Adhikari & T. Jha. (2020) Exploring the structural aspects of ureido-amino acid-based APN inhibitors: a validated comparative multi-QSAR modelling study. SAR and QSAR in Environmental Research 31:5, pages 325-345.
Read now

Articles from other publishers (9)

Shriefa Almutairi, Hanin Moh’d Kalloush, Nour A. Manoon & Sanaa K. Bardaweel. (2023) Matrix Metalloproteinases Inhibitors in Cancer Treatment: An Updated Review (2013–2023). Molecules 28:14, pages 5567.
Crossref
Saptarshi Sanyal, Sk. Abdul Amin, Priyanka Banerjee, Shovanlal Gayen & Tarun Jha. (2022) A review of MMP-2 structures and binding mode analysis of its inhibitors to strategize structure-based drug design. Bioorganic & Medicinal Chemistry 74, pages 117044.
Crossref
Sandip Kumar Baidya, Suvankar Banerjee, Nilanjan Adhikari & Tarun Jha. (2022) Selective Inhibitors of Medium-Size S1′ Pocket Matrix Metalloproteinases: A Stepping Stone of Future Drug Discovery. Journal of Medicinal Chemistry 65:16, pages 10709-10754.
Crossref
Mustapha Abdullahi, Adamu Uzairu, Gideon Adamu Shallangwa, Paul Andrew Mamza & Muhammad Tukur Ibrahim. (2022) In-silico modelling studies of 5-benzyl-4-thiazolinone derivatives as influenza neuraminidase inhibitors via 2D-QSAR, 3D-QSAR, molecular docking, and ADMET predictions. Heliyon 8:8, pages e10101.
Crossref
Saptarshi Sanyal, Sk Abdul Amin, Nilanjan Adhikari & Tarun Jha. (2021) Ligand-based design of anticancer MMP2 inhibitors: a review. Future Medicinal Chemistry 13:22, pages 1987-2013.
Crossref
Shaheen Begum, P. Jaswanthi, B. Venkata Lakshmi & K. Bharathi. (2021) QSAR studies on indole-azole Analogues using DTC tools; imidazole ring is more favorable for aromatase inhibition. Journal of the Indian Chemical Society 98:1, pages 100016.
Crossref
Mustapha Abdullahi, Gideon Adamu Shallangwa & Adamu Uzairu. (2020) In silico QSAR and molecular docking simulation of some novel aryl sulfonamide derivatives as inhibitors of H5N1 influenza A virus subtype. Beni-Suef University Journal of Basic and Applied Sciences 9:1.
Crossref
Mustapha Abdullahi, Shola Elijah Adeniji, David Ebuka Arthur & Shuaibu Musa. (2020) Quantitative structure-activity relationship (QSAR) modelling study of some novel carboxamide series as new anti-tubercular agents. Bulletin of the National Research Centre 44:1.
Crossref
Anil K. Saxena & Muneer Alam. (2020) ATP Synthase Inhibitors as Anti-tubercular Agents: QSAR Studies in Novel Substituted Quinolines. Current Topics in Medicinal Chemistry 20:29, pages 2723-2734.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.